GGrantIndex
← Leaderboards

Theranova, Llc

San Francisco, CA

Compare ↔
$20,793,838
Total funding
25
Grants

Funding over time

peak $3.5M · FY2011–25
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,793,838 · 25

By mechanism

R44$13,544,455 · 7
R43$5,034,254 · 17
SB1$2,215,129 · 1

Investigators at Theranova, Llc

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Kondapavulur T Venkateswara-Rao$615,2801 gr

Emerging Leaders

6–10 yrs in

1Vanessa Jacoby$2,501,9423 gr2Michael Jaasma$407,2792 gr3Bryan N Nowroozi$224,9811 gr4Matthew Lin$112,4761 gr

All-Time

Most funded here, all years

1Daniel Rogers Burnett$16,127,46624 gr2Vanessa Jacoby$2,501,9423 gr3Kondapavulur T Venkateswara-Rao$615,2801 gr4Michael Jaasma$407,2792 gr5Bryan N Nowroozi$224,9811 gr6Matthew Lin$112,4761 gr

Largest grants

A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$1,438,762
SB1 · FY2024 · AG
Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder$1,230,560
R44 · FY2022 · AA
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women$1,146,609
R44 · FY2018 · AG
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$1,004,449
R44 · FY2022 · AG
A novel device for improving sepsis outcomes through hemodynamic optimization$998,356
R44 · FY2015 · GM
Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder$910,489
R44 · FY2021 · AA
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women$855,031
R44 · FY2019 · AG
A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder$806,779
R44 · FY2019 · AG
A novel device for improving sepsis outcomes through hemodynamic optimization$798,113
R44 · FY2016 · GM
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$776,367
SB1 · FY2025 · AG
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$765,005
R44 · FY2020 · HD
A Photo-based Menstrual Blood Loss Metric$721,899
R44 · FY2022 · HD
A Photo-based Menstrual Blood Loss Metric$717,254
R44 · FY2021 · HD
A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder$687,183
R44 · FY2020 · AG
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location$653,381
R44 · FY2023 · AG
A Photo-based Menstrual Blood Loss Metric$608,576
R44 · FY2023 · HD
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$593,142
R44 · FY2021 · HD
A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population$575,818
R44 · FY2022 · HD
Improving the Kinetics and Reliability of Continuous Glucose Monitoring$531,442
R43 · FY2011 · DK
Improving the Kinetics and Reliability of Continuous Glucose Monitoring$476,155
R43 · FY2012 · DK